Medytox Solutions, Inc. 4
4 · Medytox Solutions, Inc. · Filed Dec 11, 2015
Insider Transaction Report
Form 4
Diamantis Christopher Eric
Director
Transactions
- Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+50,000→ 0 totalExercise: $5.00From: 2014-04-19Exp: 2017-04-19→ Common Stock (50,000 underlying) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+100,000→ 0 totalExercise: $2.50From: 2013-04-19Exp: 2017-04-19→ Common Stock (100,000 underlying) - Purchase
Common Stock
2015-10-27$1.00/sh+100,000$100,000→ 850,000 total - Disposition to Issuer
Common Stock
2015-11-02−850,000→ 0 total - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+100,000→ 0 totalExercise: $5.00From: 2013-04-19Exp: 2017-04-19→ Common Stock (100,000 underlying) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+50,000→ 0 totalExercise: $2.50From: 2014-04-19Exp: 2017-04-19→ Common Stock (50,000 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to merger agreement among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub"), and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.) in exchange for 348,193 shares of Rennova common stock.
- [F2]Cancelled pursuant to merger agreement and related transactions between Medytox and Rennova.
- [F3]Disposed of pursuant to the merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 40,963 shares of Rennova common stock at an exercise price of $6.11 per share.
- [F4]Disposed of pursuant to the merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 20,481 shares of Rennova common stock at an exercise price of $6.11 per share.